Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 30, 2015 11:18 AM ET

Pharmaceuticals

Company Overview of Roche Holding AG

Executive Profile

John C. Reed M.D., Ph.D.

Head of Pharma Research & Early Development, Roche Holding AG
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 7 different industries.

See Board Relationships
57--

Background

Dr. John C. Reed, M.D., Ph.D. has been the Head of Pharma Research & Early Development at Roche Holding AG since April 2, 2013. Dr. Reed serves as an Assistant Professor, Department of Pathology and Laboratory Medicine at the University of Pennsylvania School of Medicine. He is an Adjunct professor at the University of California San Diego (UCSD) Department of Molecular Pathology, University of Florida, University of Central Florida, and in San Diego State University's ...

Corporate Headquarters

Konzern-Hauptsitz
Basel, Basel-Stadt 4070

Switzerland

Phone: 41 61 688 11 11
Fax: 41 61 691 93 91

Board Members Memberships

2005-Present
Independent Director

Education

BA 1980
University of Virginia
PhD 1986
The University of Pennsylvania
MD
The University of Pennsylvania

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
$500.0K
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Jeffrey R. Immelt Executive Chairman and Chief Executive Officer
General Electric Company
$9.2M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Roche Holding AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.